The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $119.98

Today's change0.00 0.00%
Updated April 20 4:02 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $119.98

Today's change0.00 0.00%
Updated April 20 4:02 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc closed at (U.S.)$119.98.

Over the last five days, shares have gained 1.51% and are currently 2.79% off of the 52-week high. Shares have outperformed the S&P 500 by 43.57% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $119.98
  • High--
  • Low--
  • Bid / Ask(U.S.) $72.67 / (U.S.) $0.00
  • YTD % change+16.95%
  • Volume0
  • Average volume (10-day)63,988
  • Average volume (1-month)71,029
  • Average volume (3-month)73,621
  • 52-week range(U.S.) $63.22 to (U.S.) $123.43
  • Beta1.16
  • Trailing P/E21.33×
  • P/E 1 year forward17.97×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.62
Updated April 20 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.69%

Based on its net profit margin of 9.69%, USANA Health Sciences Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.34%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 03, 201501/03/2015Sep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014
Revenue228192188182
Total other revenue--------
Total revenue228192188182
Gross profit190157153149
Total cost of revenue38353534
Total operating expense195163159157
Selling / general / administrative158128124123
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income33292925
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax32292925
Income after tax21191917
Income tax, total119109
Net income21191917
Total adjustments to net income--------
Net income before extra. items21191917
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items21191917
Inc. avail. to common incl. extra. items21191917
Diluted net income21191917
Dilution adjustment----00
Diluted weighted average shares13131414
Diluted EPS excluding extraordinary itemsvalue per share1.661.471.351.15
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.661.471.351.15